RESPIRATORY TRACT INFECTIONS
Clinical trials for RESPIRATORY TRACT INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY TRACT INFECTIONS trials appear
Sign up with your email to follow new studies for RESPIRATORY TRACT INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Placenta cells tested as COVID fighter – but trial stopped early
Disease control TerminatedThis early-phase trial tested a new therapy called CYNK-001, which uses natural killer cells from the placenta to fight COVID-19. It enrolled only 7 adults with moderate COVID-19. The study was terminated early, so we have limited information on safety and effectiveness.
Matched conditions: RESPIRATORY TRACT INFECTIONS
Phase: PHASE1, PHASE2 • Sponsor: Celularity Incorporated • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Scientists probe mysterious loss of nose immune cells in aging
Knowledge-focused TerminatedThis observational study aims to understand why older adults lose certain immune cells (T cells) from their nasal passages, which may make them more prone to respiratory infections. Researchers will compare young adults (18-30), healthy older adults (65+), and frail older adults …
Matched conditions: RESPIRATORY TRACT INFECTIONS
Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC